Clinical trials
Terminated Phase 4 COVID-19 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 11 |
| 2021 | 9 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Government of Punjab, Specialized Healthcare and Medical Education Department | 2 |
| A. Vogel AG | 1 |
| AstraZeneca | 1 |
| Brazilian Clinical Research Institute | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Daniel Griffin | 1 |
| Erin McCreary | 1 |
| Frederick Health | 1 |
| Fundación para la Investigación del Hospital Clínico de Valencia | 1 |
| General Practitioners Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 22 |
| Coronavirus Infections | 4 |
| Respiratory Distress Syndrome | 3 |
| Thrombosis | 2 |
| Acute Kidney Injury | 1 |
| Acute Lung Injury | 1 |
| Asymptomatic Diseases | 1 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Cross Infection | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.